+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Eye Health Supplements - Global Strategic Business Report

  • PDF Icon

    Report

  • 246 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140830
The global market for Eye Health Supplements was estimated at US$2.1 Billion in 2023 and is projected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Eye Health Supplements Market - Key Trends and Drivers Summarized

How Are Eye Health Supplements Revolutionizing Vision Care and Preventing Age-Related Vision Loss?

Eye health supplements are playing a crucial role in revolutionizing vision care by providing essential nutrients that help maintain healthy vision and prevent age-related vision issues such as macular degeneration, cataracts, and dry eyes. With the increasing prevalence of eye disorders due to aging populations, lifestyle changes, and environmental factors such as prolonged screen exposure, the demand for effective eye health supplements is growing. These supplements are typically formulated with vitamins, minerals, antioxidants, and other nutrients known to support ocular health. Key ingredients include vitamins A, C, and E, zinc, lutein, zeaxanthin, and omega-3 fatty acids, all of which are critical for maintaining the structure and function of the eyes.

The introduction of eye health supplements is transforming how individuals manage their vision, particularly in the context of age-related eye conditions like age-related macular degeneration (AMD) and cataracts. AMD, for instance, is one of the leading causes of vision impairment in older adults. Research shows that certain nutrients, particularly lutein and zeaxanthin, which are found in high concentrations in the retina, can help protect the eyes from oxidative stress and blue light exposure, both of which are factors in the progression of AMD. Similarly, omega-3 fatty acids help support the lipid layer of the tear film, providing relief from dry eyes and reducing inflammation. As vision care becomes a greater priority, particularly with aging populations, eye health supplements are becoming an essential component of preventive eye care strategies.

Why Are Eye Health Supplements Critical for Maintaining Vision and Preventing Eye Disorders?

Eye health supplements are critical for maintaining vision and preventing eye disorders because they provide essential nutrients that may be lacking in a person's diet, yet are necessary for proper eye function. Many eye disorders, particularly those associated with aging, such as macular degeneration and cataracts, are linked to oxidative damage caused by free radicals. Antioxidants like vitamins C and E, lutein, and zeaxanthin found in eye supplements help neutralize free radicals, reducing oxidative stress and protecting delicate eye tissues such as the retina and lens from damage. This is particularly important for individuals at risk of AMD, a degenerative condition that affects the macula, the part of the retina responsible for central vision. Studies have shown that high doses of antioxidants and zinc can slow the progression of AMD, helping patients maintain their vision for longer periods.

In addition to their protective antioxidant properties, many eye health supplements contain nutrients that support overall eye function and health. For instance, vitamin A is crucial for maintaining the health of the cornea and is also involved in the production of rhodopsin, a protein that helps the eyes adjust to low-light conditions. Zinc plays a vital role in transporting vitamin A from the liver to the retina, where it is used to produce melanin, a protective pigment. Omega-3 fatty acids, such as DHA (docosahexaenoic acid), are important for maintaining the structural integrity of retinal cells and promoting proper eye lubrication. These nutrients not only help prevent degenerative eye conditions but also provide relief for individuals suffering from dry eye syndrome, which has become increasingly common due to excessive screen use. Eye health supplements, therefore, offer a convenient and effective way to ensure that the eyes receive the nutrients they need to stay healthy and function optimally.

What Are the Expanding Applications and Innovations in Eye Health Supplements Across Different Demographics?

The applications of eye health supplements are expanding across various demographics, from aging populations to younger individuals experiencing digital eye strain, as awareness of vision health grows. Aging adults, who are more susceptible to conditions like AMD, cataracts, and glaucoma, represent the largest consumer base for these supplements. With age-related macular degeneration being one of the leading causes of blindness in older adults, supplements containing lutein, zeaxanthin, and zinc are increasingly prescribed as part of age-related eye disease management strategies. The Age-Related Eye Disease Study (AREDS) conducted by the National Eye Institute provided strong evidence that these nutrients, along with vitamins C, E, and copper, significantly reduce the risk of advanced AMD in individuals with high-risk factors. As a result, many supplements now follow the AREDS formula, tailored specifically to address age-related vision deterioration.

Younger adults, particularly those in the workforce who spend extended periods in front of digital screens, are also turning to eye health supplements to combat the effects of blue light exposure and digital eye strain. Prolonged screen use can lead to eye fatigue, dryness, and blurred vision, which are symptoms of digital eye strain. Supplements rich in lutein and zeaxanthin, two carotenoids that naturally filter blue light, are becoming popular among individuals seeking relief from the discomfort associated with heavy screen time. Additionally, omega-3 fatty acids are being used to help alleviate dry eye symptoms, a condition that is exacerbated by staring at screens for long periods without blinking. The growing trend of using digital devices for work, entertainment, and communication is driving the demand for eye health supplements in younger populations, highlighting the broadening scope of these products.

Innovation in the eye health supplement industry is also driving new product development tailored to specific needs. Manufacturers are now offering targeted formulations that address different aspects of eye health, from blue light protection to dry eye relief and support for overall retinal health. Moreover, advancements in nutraceuticals are leading to the development of supplements with enhanced bioavailability, allowing for better absorption and effectiveness of key nutrients. Some supplements are incorporating patented ingredients like FloraGLO® lutein, which has been clinically shown to improve macular pigment levels, thereby providing superior protection against oxidative damage and blue light. Additionally, there is increasing interest in combining eye health supplements with other wellness products, such as multivitamins or brain health supplements, to provide holistic support for both vision and cognitive function. These innovations are expanding the applications of eye health supplements, making them relevant across different age groups and lifestyles.

What Factors Are Driving the Growth of the Eye Health Supplements Market?

The growth of the eye health supplements market is being driven by several key factors, including the aging global population, rising awareness of age-related eye diseases, increased screen usage leading to digital eye strain, and a growing focus on preventive healthcare. One of the most significant drivers is the increasing prevalence of age-related eye conditions, such as macular degeneration, cataracts, and glaucoma, particularly in developed regions with aging populations. As people live longer, the incidence of these conditions is rising, prompting a greater demand for supplements that can help delay the onset or progression of vision loss. The Age-Related Eye Disease Study (AREDS) has been instrumental in raising awareness about the benefits of supplements in slowing the progression of AMD, leading to a surge in demand for supplements containing antioxidants, zinc, and other key nutrients.

Another factor contributing to the growth of the eye health supplements market is the widespread use of digital devices, which has led to an increase in digital eye strain or computer vision syndrome. As more people spend extended hours in front of screens - whether for work, entertainment, or communication - the symptoms of eye fatigue, dryness, and discomfort have become more common. Supplements containing lutein, zeaxanthin, and omega-3 fatty acids are being marketed as solutions to help protect the eyes from blue light and reduce the strain associated with prolonged screen use. The growing awareness of the impact of blue light on eye health, particularly among younger demographics, is fueling demand for products that offer protection against the harmful effects of modern digital lifestyles.

Preventive healthcare is another significant driver of the eye health supplements market. Consumers are increasingly focused on maintaining their health and wellness proactively, seeking out dietary supplements as part of a broader approach to long-term health management. Eye health supplements, which are often included in this proactive health regimen, appeal to individuals who want to maintain healthy vision as they age or reduce the risk of developing eye problems later in life. Additionally, the convenience of over-the-counter eye health supplements allows individuals to incorporate vision care into their daily routines easily, further boosting their popularity.

Technological advancements in supplement formulation and delivery are also driving market growth. Improved manufacturing techniques, such as microencapsulation, have enhanced the stability and bioavailability of key ingredients like lutein and zeaxanthin, making supplements more effective and easier for the body to absorb. Moreover, the availability of customized or personalized supplements tailored to specific nutritional needs is increasing consumer interest in eye health products. With the integration of wearable health tech and digital health platforms, individuals can now monitor their health more closely, further driving the demand for supplements that support their wellness goals.

In conclusion, the eye health supplements market is experiencing substantial growth due to the rising awareness of the importance of maintaining vision health, the increasing prevalence of age-related eye diseases, and the growing need for protection against digital eye strain. With continued innovation in product formulations and an expanding consumer base that spans different age groups and lifestyles, eye health supplements are set to remain a vital component of both preventive and therapeutic vision care strategies in the years to come. As demand for holistic health solutions continues to grow, eye health supplements will play an increasingly important role in helping individuals maintain healthy vision and quality of life.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Tablet segment, which is expected to reach US$1.2 Billion by 2030 with a CAGR of a 4.5%. The Capsule segment is also set to grow at 5.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $551.1 Million in 2023, and China, forecasted to grow at an impressive 7.3% CAGR to reach $629.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Eye Health Supplements Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Eye Health Supplements Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Eye Health Supplements Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Alliance Pharma Plc, Amway Corporation, Novartis AG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

  • Alliance Pharma Plc
  • Amway Corporation
  • Novartis AG
  • Pfizer, Inc.
  • The Nature's Bounty Co.
  • Valeant Pharmaceuticals International, Inc.
  • Vitabiotics Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Eye Health Supplements - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Vision Impairment and Eye Diseases Driving Demand for Eye Health Supplements
  • Advancements in Nutritional Science Enhancing Effectiveness of Eye Health Formulas
  • Increasing Consumer Awareness of Preventive Health Care Fueling Supplement Use
  • Impact of Aging Populations Globally on Eye Health Supplement Markets
  • Market Trends Toward Organic and Natural Ingredient-Based Supplements
  • Influence of Digital Screen Exposure on the Growing Demand for Eye Supplements
  • Expansion of Distribution Channels Including Online Retail Boosting Accessibility
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Eye Health Supplements Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Eye Health Supplements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Tablet by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Tablet by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Tablet by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Capsule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Capsule by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Capsule by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Age-related Macular Degeneration (AMD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Age-related Macular Degeneration (AMD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Age-related Macular Degeneration (AMD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Dry Eye Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Dry Eye Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Dry Eye Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Cataract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Cataract by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Cataract by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Inflammation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Inflammation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Inflammation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 29: USA Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: USA Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: USA 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: USA Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: USA 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: Canada 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: Canada 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
JAPAN
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 41: Japan Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: Japan Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: Japan 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: Japan 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
CHINA
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 47: China Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: China Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: China 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: China Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: China 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
EUROPE
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 53: Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Eye Health Supplements by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Europe Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: Europe 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 59: Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: Europe Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 61: Europe 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
FRANCE
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 62: France Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: France Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 64: France 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 65: France Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: France Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 67: France 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
GERMANY
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 68: Germany Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 70: Germany 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 71: Germany Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 72: Germany Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 73: Germany 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
ITALY
  • Table 74: Italy Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 76: Italy 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 77: Italy Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: Italy Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 79: Italy 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 80: UK Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: UK Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 82: UK 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 83: UK Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: UK Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 85: UK 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
SPAIN
  • Table 86: Spain Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Spain Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 88: Spain 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 89: Spain Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 90: Spain Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 91: Spain 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
RUSSIA
  • Table 92: Russia Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Russia Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 94: Russia 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 95: Russia Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 96: Russia Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 97: Russia 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 98: Rest of Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of Europe Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 100: Rest of Europe 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 101: Rest of Europe Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 102: Rest of Europe Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 103: Rest of Europe 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Eye Health Supplements by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Eye Health Supplements by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 107: Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Form - Tablet, Capsule and Other Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 108: Asia-Pacific Historic Review for Eye Health Supplements by Form - Tablet, Capsule and Other Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 109: Asia-Pacific 16-Year Perspective for Eye Health Supplements by Form - Percentage Breakdown of Value Sales for Tablet, Capsule and Other Forms for the Years 2014, 2024 & 2030
  • Table 110: Asia-Pacific Recent Past, Current & Future Analysis for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 111: Asia-Pacific Historic Review for Eye Health Supplements by Indication - Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 112: Asia-Pacific 16-Year Perspective for Eye Health Supplements by Indication - Percentage Breakdown of Value Sales for Age-related Macular Degeneration (AMD), Dry Eye Syndrome, Cataract, Inflammation and Other Indications for the Years 2014, 2024 & 2030
AUSTRALIA
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Eye Health Supplements Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alliance Pharma Plc
  • Amway Corporation
  • Novartis AG
  • Pfizer, Inc.
  • The Nature's Bounty Co.
  • Valeant Pharmaceuticals International, Inc.
  • Vitabiotics Ltd.

Table Information